JPRN-UMIN000000737已完成3 期
Phase II trial of endoscopic submucosal dissection to expand indication for early gastric cancer (JCOG0607) - Phase II trial of endoscopic submucosal dissection to expand indication for early gastric cancer (JCOG0607)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 470 人开始时间: 2007年6月8日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 470
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Impossible to discontinue anticoagulant or antiplatelet medications. 2) Simultaneous or metachronous (within 5 years) double cancers except intramucosal tumor curable with local therapy. 3) Women during pregnancy or breast-feeding. 4) Psychosis. 5) Systemic steroids medication. 6) Active bacterial or fungous infection. 7) History of myocardial infarction or unstable angina pectoris within three months. 8) Uncontrollable hypertension. 9) Uncontrollable diabetes mellitus or administration of insulin. 10) Severe respiratory disease requiring continuous oxygen therapy.
研究者
相似试验
已完成
2 期
A phase II study of laparoscopy assisted distal gastrectomy with nodal dissection for clinical stage I gastric cancer (JCOG0703)clinical stage I gastric cancerJPRN-UMIN000000874Japan Clinical Oncology Group(JCOG)170
已完成
2 期
Randomized phase II study of the Induction Chemotherapy with Docetaxel alone vs CDDP+Docetaxel for c-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)JPRN-C000000032Japan Clinical Oncology Group(JCOG)80
已完成
2 期
A phase II trial of pre-operative chemoradiotherapy followed by surgical resection in Pancoast tumors: initial report of Japan Clinical Oncology Group trial (JCOG 9806)JPRN-C000000031Japan Clinical Oncology Group(JCOG)75
已完成
2 期
Randomized phase II study of two induction treatments of melphalan, prednisolone, plus bortezomib, JCOG-MPB versus modified PETHEMA-MPB, in elderly patients or non-elderly patients refusing transplant with untreated symptomatic myeloma(JCOG1105, IMPROVE-MPB study)Elderly patients or non-elderly patients refusing transplant with untreated symptomatic myelomaJPRN-UMIN000011180Japan Clinical Oncology Group (JCOG)91
已完成
2 期
Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)JPRN-C000000092Japan Clinical Oncology Group(JCOG)108